There's a big problem on college campuses that is going largely unnoticed. Many students are battling with food insecurity and are finding themselves struggling to afford nutritional meals. Rachel Sumekh, founder and CEO of Swipe Out Hunger, stopped by to share how her organization is trying to fix the problem. Swipe Out Hunger allows college students to donate their extra meal kit points to their peers. The non-profit is already on 35 campuses and has provided 1.4 million meals. Sumekh explains why it's important the same kids that received free meals at school before college are not forgotten about once they pursue higher education. Sumekh points out that hundreds of millions of dollars are wasted by students who don't use their meal plans. To make sure these are better utilized, she explains how relationships with food companies like Sodexo are getting involved with the program to save those dollars.

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More